Vera Tarjányi

Dr. Vera Tarjányi

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2024 in Agriculture
Verified
Journal Article
Open access
PDF file
Csótó AndrásCsótó András
Csótó András
GTGyörgy Tóth
György Tóth
PRPeter Riczu
Peter Riczu
AZAndrea Zabiák
Andrea Zabiák
VTVera Tarjányi
Vera Tarjányi
ESErzsébet Sándor
Erzsébet Sándor
Microbial biostimulants that promote plant growth and abiotic stress tolerance are promising alternatives to chemical fertilizers and pesticides. Although Trichoderma fungi are known biocontrol agents, their biostimulatory potential has been scarcely studied in field conditions. Here, the mixture of two endophytic Trichoderma strains (Trichoderma afroharzianum TR04 and Trichoderma simmonsii TR05) was tested as biostimulant in the form of foliar spray on young (BBCH 15-16) maize (5.7 ha) and sunflower (5.7 and 11.3 ha) fields in Hungary. The stimulatory effect was characterized by changes in plant height, the number of viable leaves, and the chlorophyll content, combined with yield sensor collected harvest data. In all trials, the foliar treatment with Trichoderma spores increased photosynthetic potential: the number of viable leaves increased by up to 6.7% and the SPAD index by up to 19.1% relative to the control. In extreme drought conditions, maize yield was doubled (from 0.587 to 1.62 t/ha, p < 0.001). The moisture content of the harvested seeds, as well as sunflower height, consistently increased post-treatment. We concluded that foliar spraying of young plants with well-selected endophytic Trichoderma strains can stimulate growth, photosynthesis, and drought tolerance in both monocot maize and dicots sunflower crops in field conditions.

26 April 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
Anna SzilagyiAnna Szilagyi
Anna Szilagyi
TBTakács Barbara
Takács Barbara
RSReka Szekeres
Reka Szekeres
VTVera Tarjányi
Vera Tarjányi
BJBela Juhasz
Bela Juhasz
BVBalazs Varga
Balazs Varga
Ischemic eye diseases are major causes of vision impairment. Thus, potential retinoprotective effects of N’N-dimethyltryptamine (DMT) were investigated. To inhibit its rapid breakdown by monoamine-oxidase A (MAO-A) enzyme, DMT was co-administered with harmaline, a β-carboline in the Amazonian Ayahuasca brew. Using ligation, 60 min of ischemia was provoked in eyes of rats, followed by 7 days of reperfusion whilst animals received harmaline alone, DMT + harmaline, or vehicle treatment. After 1 week of reperfusion, electroretinographical (ERG) measurements, histological analysis, and Western blot were performed. Harmaline alone exhibited retinoprotection in ischemia–reperfusion (I/R) which was, surprisingly, counterbalanced by DMT in case of co-administration. As both MAO-A inhibition and DMT increase serotoninergic tone synergistically, communicated to be anti-ischemic, thus, involvement of other pathways was investigated. Based on our experiments, DMT and harmaline exert opposite effects on important ocular proteins such as PARP1, NFκB, MMP9, or HSP70, each having a critical role in a different mechanism of eye-ischemia-related pathologies, e.g., cell death, inflammation, tissue destruction, and oxidative stress. Since DMT is proclaimed to be a promising drug candidate, its potentially undesirable effect on eye-ischemia should be further investigated. Meanwhile, this experiment revealed the potential therapeutic effect of MAO-A inhibitor harmaline in I/R-related eye diseases.

25 May 2024 in GeroScience
Verified
Journal Article
Open access
PDF file
ASAnna Szilágyi
Anna Szilágyi
TBTakács Barbara
Takács Barbara
RSReka Szekeres
Reka Szekeres
VTVera Tarjányi
Vera Tarjányi
DNDávid Nagy
Dávid Nagy
BVBalazs Varga
Balazs Varga
Aging is accompanied by an increased prevalence of degenerative conditions, including those affecting ocular health, which significantly impact quality of life and increase the burden on healthcare systems. Among these, retinal aging is of particular concern due to its direct link to vision impairment, a leading cause of disability in the elderly. Vision loss in the aging population is associated with heightened risks of cognitive decline, social isolation, and morbidity. This study addresses the critical gap in our understanding of modifiable lifestyle factors, such as physical exercise, that may mitigate retinal aging and its related pathologies. We investigated the effects of different exercise regimens—voluntary (recreational-type) and forced (high-intensity)—on the retinal health of aging Wistar rats (18-month-old), serving as a model for studying the translational potential of exercise interventions in humans. Male Wistar rats were divided into four groups: a young control (3-month-old) for baseline comparison, an aged sedentary control, an aged group engaging in voluntary exercise via a running wheel in their cage, and an aged group subjected to forced exercise on a treadmill for six sessions of 20 min each per week. After a 6-month experimental period, we assessed retinal function via electroretinography (ERG), measured retinal thickness histologically, and analyzed protein expression changes relevant to oxidative stress, inflammation, and anti-aging mechanisms. Our findings reveal that voluntary exercise positively impacts retinal function and morphology, reducing oxidative stress and inflammation markers while enhancing anti-aging protein expression. In contrast, forced exercise showed diminished benefits. These insights underscore the importance of exercise intensity and preference in preserving retinal health during aging. The study highlights the potential of recreational physical activity as a non-invasive strategy to counteract retinal aging, advocating for further research into exercise regimens as preventative therapies for age-related ocular degenerations.

Verified
Journal Article
Open access
PDF file
RSReka Szekeres
Reka Szekeres
DPDaniel Priksz
Daniel Priksz
Rita KissRita Kiss
Rita Kiss
DRDANA DIANA ROMANESCU
DANA DIANA ROMANESCU
BJBela Juhasz
Bela Juhasz
BJBela Juhasz
Bela Juhasz
This study evaluates the potential therapeutic effects of anthocyanin-rich Prunus cerasus (sour cherry) extract (PCE) on atherosclerosis-associated cardiac dysfunction, described by the impairment of the NO-PKG (nitric oxide–protein kinase G) pathway and the antioxidant capacity. Initially, a rabbit model of atherosclerotic cardiovascular disease was established by administering a cholesterol-rich diet, enabling the examination of the impact of 9 g/kg PCE on the pre-existing compromised cardiovascular condition. After that, the animals were divided into four groups for 12 weeks: the (1) untreated control group; (2) PCE-administered healthy rabbits; (3) hypercholesterolemic (HC) group kept on an atherogenic diet; and (4) PCE-treated HC group. Dyslipidemia, impaired endothelial function, and signs of diastolic dysfunction were evident in hypercholesterolemic rabbits, accompanied by a reduced cardiac expression of eNOS (endothelial nitric oxide synthase), PKG, and SERCA2a (sarco/endoplasmic reticulum calcium ATPase 2a). Subsequent PCE treatment improved the lipid profile and the cardiac function. Additionally, PCE administration was associated with elevated myocardial levels of eNOS, PKG, and SERCA2a, while no significant changes in the vascular status were observed. Western blot analysis further revealed hypercholesterolemia-induced increase and PCE-associated reduction in heme oxygenase-1 expression. The observed effects of anthocyanins indicate their potential as a valuable addition to the treatment regimen for atherosclerosis-associated cardiac dysfunction.

Verified
Journal Article
Open access
PDF file
VTVera Tarjányi
Vera Tarjányi
ÁMÁkos Ménes
Ákos Ménes
LHLeila Hamid
Leila Hamid
AKAndrea Kurucz
Andrea Kurucz
DPDaniel Priksz
Daniel Priksz
BJBela Juhasz
Bela Juhasz
Numerous studies have indicated a link between vaccines and the exacerbation of autoimmune diseases including rheumatoid arthritis (RA). However, there is no consensus in clinical practice regarding the optimal timing of immunization. Therefore, this study aimed to investigate the impact of the 3Fluart influenza vaccine on the complete Freund’s adjuvant (CFA)-induced chronic arthritis rat model and to identify new biomarkers with clinical utility. CFA was injected into the plantar surface of one hind paw and the root of the tail on day 0, and the tail root injection was repeated on day 1. Flu vaccination was performed on day 1 or 7. Paw volume was measured by plethysmometry, mechanonociceptive threshold by dynamic plantar aesthesiometry, neutrophil myeloperoxidase (MPO) activity, and vascular leakage using in vivo optical imaging throughout the 21-day experiment. Inflammatory markers were determined by Western blot and histopathology. CFA-induced swelling, an increase in MPO activity, plasma extravasation in the tibiotarsal joint. Mechanical hyperalgesia of the hind paw was observed 3 days after the injection, which gradually decreased. Co-administration of the flu vaccine on day 7 but not on day 1 resulted in significantly increased heme oxygenase 1 (HO-1) expression. The influenza vaccination appears to have a limited impact on the progression and severity of the inflammatory response and associated pain. Nevertheless, delayed vaccination could alter the disease activity, as indicated by the findings from assessments of edema and inflammatory biomarkers. HO-1 may serve as a potential marker for the severity of inflammation, particularly in the case of delayed vaccination. However, further investigation is needed to fully understand the regulation and role of HO-1, a task that falls outside the scope of the current study.

19 February 2025 in GeroScience
Verified
Journal Article
Open access
PDF file
ASAnna Szilágyi
Anna Szilágyi
TBTakács Barbara
Takács Barbara
RSReka Szekeres
Reka Szekeres
VTVera Tarjányi
Vera Tarjányi
DNDávid Nagy
Dávid Nagy
BVBalazs Varga
Balazs Varga